Íomhá chlúdaigh

Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone

Olanzapine, aripiprazole and risperidone are atypical antipsychotics or neuroleptics widely used for schizophrenia treatment. They induce various adverse drug reactions depending on their mechanisms of action: metabolic effects, such as weight gain and alterations of glucose and lipid metabolism; hy...

Cur síos iomlán

Sábháilte in:

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Paula Soria-Chacartegui (Údar), Gonzalo Villapalos-García (Údar), Pablo Zubiaur (Údar), Francisco Abad-Santos (Údar), Dora Koller (Údar)
Formáid:	LEABHAR
Foilsithe / Cruthaithe:	Frontiers Media S.A., 2021-07-01T00:00:00Z.
Ábhair:	article
Rochtain ar líne:	Connect to this object online.
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla

Dexketoprofen Pharmacokinetics is not Significantly Altered by Genetic Polymorphism
de réir: Gina Mejía-Abril, et al.
Foilsithe / Cruthaithe: (2021)

Impact of polymorphisms in CYP and UGT enzymes and ABC and SLCO1B1 transporters on the pharmacokinetics and safety of desvenlafaxine
de réir: Sofía Calleja, et al.
Foilsithe / Cruthaithe: (2023)

The Pharmacogenetics of Treatment with Quetiapine
de réir: María Ortega-Ruiz, et al.
Foilsithe / Cruthaithe: (2022)

Clinical Relevance of Novel Polymorphisms in the Dihydropyrimidine Dehydrogenase (<i>DPYD</i>) Gene in Patients with Severe Fluoropyrimidine Toxicity: A Spanish Case-Control Study
de réir: Paula Soria-Chacartegui, et al.
Foilsithe / Cruthaithe: (2021)

Association Studies in Clinical Pharmacogenetics
de réir: Pablo Zubiaur, et al.
Foilsithe / Cruthaithe: (2022)

Variants in <i>COMT</i>, <i>CYP3A5</i>, <i>CYP2B6,</i> and <i>ABCG2</i> Alter Quetiapine Pharmacokinetics
de réir: Pablo Zubiaur, et al.
Foilsithe / Cruthaithe: (2021)

Evaluation of the role of metabolizing enzymes and transporter variants in ezetimibe pharmacokinetics
de réir: Eva González-Iglesias, et al.
Foilsithe / Cruthaithe: (2024)

Effects of Cytochrome P450 and Transporter Polymorphisms on the Bioavailability and Safety of Dutasteride and Tamsulosin
de réir: Gonzalo Villapalos-García, et al.
Foilsithe / Cruthaithe: (2021)

Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline
de réir: Pablo Zubiaur, et al.
Foilsithe / Cruthaithe: (2022)

Genetic Variation in <i>CYP2D6</i> and <i>SLC22A1</i> Affects Amlodipine Pharmacokinetics and Safety
de réir: Paula Soria-Chacartegui, et al.
Foilsithe / Cruthaithe: (2023)

Use of Exposure Data to Establish Causality in Drug-Adverse Event Relationships: An Example with Desvenlafaxine
de réir: Andrea Rodríguez-Lopez, et al.
Foilsithe / Cruthaithe: (2024)

Successful treatment with olanzapine and aripiprazole of a schizophrenic patient who developed priapism after switching from risperidone to paliperidone
de réir: Saki Kawahara, et al.
Foilsithe / Cruthaithe: (2024)

Genetic variation in UGT1A1 is not associated with altered liver biochemical parameters in healthy volunteers participating in bioequivalence trials
de réir: Eva González-Iglesias, et al.
Foilsithe / Cruthaithe: (2024)

Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post‐surgical pain
de réir: Ana Casajús, et al.
Foilsithe / Cruthaithe: (2024)

CYP2C8*3 and *4 define CYP2C8 phenotype: An approach with the substrate cinitapride
de réir: Diana María Campodónico, et al.
Foilsithe / Cruthaithe: (2022)

Bioequivalence study of tablet forms of risperidone, olanzapine and quetiapine in healthy volunteers
de réir: V. V. Pisarev, et al.
Foilsithe / Cruthaithe: (2013)

Comparative evaluation of pancreatic histopathology of rats treated with olanzapine, risperidone and streptozocin
de réir: Rehmat Shah, et al.
Foilsithe / Cruthaithe: (2018)

Utility of a Laboratory Alert System for Detecting Adverse Drug Reactions in Hospitalised Patients: Hyponatremia and Rhabdomyolysis
de réir: Mónica Valdés-Garicano, et al.
Foilsithe / Cruthaithe: (2022)

Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives
de réir: Álvaro Pinto-Merino, et al.
Foilsithe / Cruthaithe: (2022)

Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels
de réir: Minami Tasaki, et al.
Foilsithe / Cruthaithe: (2021)

Receptors Involved in Mental Disorders and the Use of Clozapine, Chlorpromazine, Olanzapine, and Aripiprazole to Treat Mental Disorders
de réir: Ronald Mlambo, et al.
Foilsithe / Cruthaithe: (2023)

Risperidone or Aripiprazole Can Resolve Autism Core Signs and Symptoms in Young Children: Case Study
de réir: Hamza A. Alsayouf, et al.
Foilsithe / Cruthaithe: (2021)

Urgent Hospital Admissions Caused by Adverse Drug Reactions and Medication Errors-A Population-Based Study in Spain
de réir: Gina Mejía, et al.
Foilsithe / Cruthaithe: (2020)

Effect on Body Weight and Adipose Tissue by Cariprazine: A Head-to-Head Comparison Study to Olanzapine and Aripiprazole in Rats
de réir: László-István Bába, et al.
Foilsithe / Cruthaithe: (2020)

Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole
de réir: Dolores Ochoa, et al.
Foilsithe / Cruthaithe: (2020)

Chaotropic effect of trifluoroacetic and perchloric acid on B-cyclodextrin inclusion complexation process with risperidone, olanzapine and their selected impurities
de réir: Đajić Nevena, et al.
Foilsithe / Cruthaithe: (2020)

Gene Polymorphisms Affecting the Pharmacokinetics and Pharmacodynamics of Donepezil Efficacy
de réir: Jin Lu, et al.
Foilsithe / Cruthaithe: (2020)

Effect of genetic polymorphisms on the interplay of P-glycoprotein transporter and cytochrome P450 enzymes: Pharmacokinetics of risperidone
de réir: Yong-Bok Lee
Foilsithe / Cruthaithe: (2016)

An Investigational Study on the Role of <i>CYP2D6</i>, <i>CYP3A4</i> and <i>UGT</i>s Genetic Variation on Fesoterodine Pharmacokinetics in Young Healthy Volunteers
de réir: Andrea Rodríguez-Lopez, et al.
Foilsithe / Cruthaithe: (2024)

Population Pharmacodynamic Models of Risperidone on PANSS Total Scores and Prolactin Levels in Schizophrenia
de réir: Zhiwei Huang, et al.
Foilsithe / Cruthaithe: (2024)

Comparison of risperidone and aripiprazole in the treatment of preschool children with disruptive behavior disorder and attention deficit-hyperactivity disorder: A randomized clinical trial
de réir: Parvin Safavi, et al.
Foilsithe / Cruthaithe: (2016)

Genetic Variation in <i>CYP2D6</i>, <i>UGT1A4</i>, <i>SLC6A2</i> and <i>SLCO1B1</i> Alters the Pharmacokinetics and Safety of Mirabegron
de réir: Paula Soria-Chacartegui, et al.
Foilsithe / Cruthaithe: (2024)

Antecedentes de las curas en ambiente húmedo (CAH): El "método español" de tratamiento de heridas de guerra y el Hospital Sueco-Noruego de Alcoy History of cures in moist enviroment (CME): The "Spanish Method" of wound war treatment and the Swedish-Norwegian hospital in Alcoy
de réir: Francisco Enrique Moltó Abad
Foilsithe / Cruthaithe: (2013)

Impact of genetic polymorphisms on the pharmacokinetics and pharmacodynamics of lenvatinib in patients with hepatocellular carcinoma
de réir: Hironao Okubo, et al.
Foilsithe / Cruthaithe: (2022)

Understanding inter-individual variability in pharmacokinetics/pharmacodynamics of aripiprazole in children with tic disorders: Individualized administration based on physiological development and CYP2D6 genotypes
de réir: Yingying Xin, et al.
Foilsithe / Cruthaithe: (2022)

Pharmacokinetics and Pharmacodynamics of (S)-Ketoprofen Co-Administered with Caffeine: A Preclinical Study in Arthritic Rats
de réir: Raúl Medina-López, et al.
Foilsithe / Cruthaithe: (2018)

Pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil NanoCrystal Dispersion used for initiation of the long-acting antipsychotic aripiprazole lauroxil
de réir: Marjie L. Hard, et al.
Foilsithe / Cruthaithe: (2019)

Clinical Observation of Gene Polymorphism of Olanzapine or Aprepitant in Prevention of CINV
de réir: Jin Y, et al.
Foilsithe / Cruthaithe: (2021)

CYP2D6 polymorphisms and their influence on risperidone treatment
de réir: Puangpetch A, et al.
Foilsithe / Cruthaithe: (2016)

Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen
de réir: Ioannis Loisios-Konstantinidis, et al.
Foilsithe / Cruthaithe: (2020)